Jon D Hoffmann

Array ( [id] => 5436226 [patent_doc_number] => 20090170813 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'Hypophosphorous Acid Derivatives and their Therapeutical Applications' [patent_app_type] => utility [patent_app_number] => 12/083830 [patent_app_country] => US [patent_app_date] => 2006-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17668 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20090170813.pdf [firstpage_image] =>[orig_patent_app_number] => 12083830 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5539795 [patent_doc_number] => 20090221600 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'PYRIDO-PYRIDIMIDINE DERIVATIVES USEFUL AS ANTIINFLAMMATORY AGENTS' [patent_app_type] => utility [patent_app_number] => 12/088538 [patent_app_country] => US [patent_app_date] => 2006-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28036 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20090221600.pdf [firstpage_image] =>[orig_patent_app_number] => 12088538 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7687414 [patent_doc_number] => 20090176877 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'OSELTAMIVIR PHOSHATE GRANULE AND PREPARATION METHOD THEREOF' [patent_app_type] => utility [patent_app_number] => 12/225935 [patent_app_country] => US [patent_app_date] => 2006-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2758 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20090176877.pdf [firstpage_image] =>[orig_patent_app_number] => 12225935 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9389444 [patent_doc_number] => 08686042 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-01 [patent_title] => 'GSK-3 inhibitors' [patent_app_type] => utility [patent_app_number] => 11/996962 [patent_app_country] => US [patent_app_date] => 2006-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 5159 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11996962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5490953 [patent_doc_number] => 20090292024 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-26 [patent_title] => 'SUBSTITUTED PROPANAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME' [patent_app_type] => utility [patent_app_number] => 11/996268 [patent_app_country] => US [patent_app_date] => 2006-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 71078 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20090292024.pdf [firstpage_image] =>[orig_patent_app_number] => 11996268 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6127874 [patent_doc_number] => 20110086852 [patent_country] => US [patent_kind] => A2 [patent_issue_date] => 2011-04-14 [patent_title] => 'PHARMACEUTICAL COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 11/995878 [patent_app_country] => US [patent_app_date] => 2006-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20360 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A2/0086/20110086852.pdf [firstpage_image] =>[orig_patent_app_number] => 11995878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6127874 [patent_doc_number] => 20110086852 [patent_country] => US [patent_kind] => A2 [patent_issue_date] => 2011-04-14 [patent_title] => 'PHARMACEUTICAL COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 11/995878 [patent_app_country] => US [patent_app_date] => 2006-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20360 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A2/0086/20110086852.pdf [firstpage_image] =>[orig_patent_app_number] => 11995878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6025986 [patent_doc_number] => 20110053910 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => '2 -HETEROCYCLYLOXYBENZOYL AMINO HETEROCYCLYL COMPOUNDS AS MODULATORS OF GLUCOKINASE FOR THE TREATMENT OF TYPE 2 DIABETES' [patent_app_type] => utility [patent_app_number] => 11/995076 [patent_app_country] => US [patent_app_date] => 2006-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25854 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20110053910.pdf [firstpage_image] =>[orig_patent_app_number] => 11995076 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5022262 [patent_doc_number] => 20070148228 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-28 [patent_title] => 'Solid oral dosage form containing an enhancer' [patent_app_type] => utility [patent_app_number] => 11/450641 [patent_app_country] => US [patent_app_date] => 2006-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 13215 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20070148228.pdf [firstpage_image] =>[orig_patent_app_number] => 11450641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8802440 [patent_doc_number] => 08440715 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-14 [patent_title] => 'Treatment of sleep-wake disorders' [patent_app_type] => utility [patent_app_number] => 11/921995 [patent_app_country] => US [patent_app_date] => 2006-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15360 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11921995 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4728050 [patent_doc_number] => 20080207594 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Use of Gsk-3 Inhibitors for Preventing and Treating Pancreatic Autoimmune Disorders' [patent_app_type] => utility [patent_app_number] => 11/913612 [patent_app_country] => US [patent_app_date] => 2006-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 15539 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20080207594.pdf [firstpage_image] =>[orig_patent_app_number] => 11913612 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5112549 [patent_doc_number] => 20070196464 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-23 [patent_title] => 'Solid oral dosage form containing an enhancer' [patent_app_type] => utility [patent_app_number] => 11/400689 [patent_app_country] => US [patent_app_date] => 2006-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 12784 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20070196464.pdf [firstpage_image] =>[orig_patent_app_number] => 11400689 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9749871 [patent_doc_number] => 08841348 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-23 [patent_title] => 'Anti-inflammatory formulation' [patent_app_type] => utility [patent_app_number] => 11/918185 [patent_app_country] => US [patent_app_date] => 2006-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6694 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11918185 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5338065 [patent_doc_number] => 20090054529 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'Flow Path Conditioner System' [patent_app_type] => utility [patent_app_number] => 11/887872 [patent_app_country] => US [patent_app_date] => 2006-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 18743 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20090054529.pdf [firstpage_image] =>[orig_patent_app_number] => 11887872 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6026338 [patent_doc_number] => 20110053969 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'NOVEL DIAZASIPIROAKANES AND THEIR USE FOR TREATMENT OF CCR8 MEDIATED DISEASES' [patent_app_type] => utility [patent_app_number] => 11/910580 [patent_app_country] => US [patent_app_date] => 2006-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8140 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20110053969.pdf [firstpage_image] =>[orig_patent_app_number] => 11910580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5485891 [patent_doc_number] => 20090275656 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'Medicinal Compositions of Salts, Chelates and/or Free Acids of Alpha Hydroxyl Organic Acids and Related Processes and Methods' [patent_app_type] => utility [patent_app_number] => 11/886345 [patent_app_country] => US [patent_app_date] => 2006-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15678 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20090275656.pdf [firstpage_image] =>[orig_patent_app_number] => 11886345 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5343396 [patent_doc_number] => 20090182046 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-16 [patent_title] => 'Cosmetic Compositions Containing Esters Based on 2-Propylheptanol' [patent_app_type] => utility [patent_app_number] => 11/886623 [patent_app_country] => US [patent_app_date] => 2006-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31190 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 46 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20090182046.pdf [firstpage_image] =>[orig_patent_app_number] => 11886623 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6257663 [patent_doc_number] => 20100029696 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'INDOLYLAMINO QUINAZOLINE DERIVATIVES AS ANTITUMOR AGENTS' [patent_app_type] => utility [patent_app_number] => 11/817391 [patent_app_country] => US [patent_app_date] => 2006-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23151 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20100029696.pdf [firstpage_image] =>[orig_patent_app_number] => 11817391 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5338059 [patent_doc_number] => 20090054523 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'Use of a Fatty Acid Composition Containing DHA for the Production of a Medical Product or a Food Stuff for the Treatment of Amyloidos-Related Diseases' [patent_app_type] => utility [patent_app_number] => 11/795800 [patent_app_country] => US [patent_app_date] => 2006-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8693 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20090054523.pdf [firstpage_image] =>[orig_patent_app_number] => 11795800 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5290898 [patent_doc_number] => 20090023628 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'Cosmetic Composition and a Process for Preparing This Cosmetic Composition and a Cosmetic Product' [patent_app_type] => utility [patent_app_number] => 11/794428 [patent_app_country] => US [patent_app_date] => 2005-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10321 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20090023628.pdf [firstpage_image] =>[orig_patent_app_number] => 11794428 [rel_patent_id] =>[rel_patent_doc_number] =>)